AD

Alan Hornsby Davidson

BB British Biotechnology: 8 patents #1 of 30Top 4%
CT Chroma Therapeutics: 7 patents #3 of 23Top 15%
BP British Biotech Pharmaceuticals: 5 patents #17 of 56Top 35%
GT Governing Council Of The University Of Toronto: 1 patents #286 of 760Top 40%
UM University Of Massachusetts: 1 patents #755 of 1,810Top 45%
Overall (All Time): #162,669 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDate
11530394 Anti-CRISPR compounds and methods of use Erik J. Sontheimer, Karen Maxwell, April Pawluk, Yan Zhang, Jooyoung Lee +1 more 2022-12-20
9725407 HDAC inhibitors David Festus Charles Moffat, Francesca Ann Day, Alastair David Graham Donald 2017-08-08
9636409 Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters Alan Hastings Drummond, David Festus Charles Moffat, Alastair David Graham Donald, Stephen John Davies 2017-05-02
9273003 Methods of treating lymphoma and rheumatoid arthritis with cyclopentyl (2S)-cyclohexyl[({6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl}methyl)amino]acetate David Festus Charles Moffat, Francesca Ann Day, Alastair David Graham Donald 2016-03-01
9133104 Enzyme inhibitors Sanjay Ratilal Patel, Francesca Mazzei, Stephen John Davies, Alan Hastings Drummond, David Festus Charles Moffat +2 more 2015-09-15
8962825 Hydroxamates as inhibitors of histone deacetylase David Charles Festus Moffat, Sanjay Ratilal Patel, Francesca Ann Day, Andrew James Belfield, Alistair David Graham Donald +1 more 2015-02-24
8686032 Enzyme inhibitors Sanjay Ratilal Patel, Francesca Mazzei, Stephen John Davies, Alan Hastings Drummond, David Festus Charles Moffat +2 more 2014-04-01
8637547 Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases David Charles Festus Moffat, Francesca Ann Day, Alistair David Graham Donald 2014-01-28
8211900 DHFR enzyme inhibitors 2012-07-03
8148531 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity Stephen John Davies, David Festus Charles Moffat 2012-04-03
7973181 Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity Sanjay Ratilal Patel, David Festus Charles Moffat 2011-07-05
7939666 Enzyme inhibitors Sanjay Ratilal Patel, Francesca Mazzei, Stephen John Davies, Alan Hastings Drummond, David Festus Charles Moffat +2 more 2011-05-10
5910609 Compounds Colin Campion, Jonathan P. Dickens, Michael J. Crimmin 1999-06-08
5703059 Disaccharide ligands for selectins Nigel Mark Allanson 1997-12-30
5530161 Hydroxamic acid based collagenase inhibitors Colin Campion, Jonathan P. Dickens, Michael J. Crimmin 1996-06-25
5514677 Hydroxamic acid based collagenase inhibitors Jonathan P. Dickens, Michael J. Crimmin 1996-05-07
5453438 Hydroxamic acid based collagenase inhibitors Colin Campion, Jonathan P. Dickens, Michael J. Crimmin 1995-09-26
5428168 Lactol PAF antagonists Mark Whittaker, Zoe Marie Spavold, Stephen A. Bowles 1995-06-27
5314880 Benzimidazole derivatives Mark Whittaker, Christopher David Floyd, Jonathan P. Dickens 1994-05-24
5310763 Hydroxamino acid based collagenase inhibitors Colin Campion, Jonathan P. Dickens, Michael J. Crimmin 1994-05-10
5308864 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones and the corresponding hydroxy acids Christopher Norman Lewis, Christopher David Floyd, Jonathan P. Dickens 1994-05-03
5304604 Hydroxamic acid collagenase inhibotors Jonathan P. Dickens, Michael J. Crimmin 1994-04-19
5300524 Spirocyclic PAF antagonists Mark Whittaker, Zoe Marie Spavold 1994-04-05
5240958 Hydroxamic acid based collagenase inhibitors Colin Campion, Jonathan P. Dickens, Michael J. Crimmin 1993-08-31
5210228 Decaline based HMC-COA reductase inhibitors with two C-6 substituents Richard Simon Todd, Christopher Norman Lewis, Alan Hastings Drummond 1993-05-11